XNYS · Healthcare · Medical Devices
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 | Q1 2026 | -0.28 | 0.10 | +135.71% | $204.6M | ✅ Beat | -16.43% | -20.95% | -26.26% |
| 2026-02-11 | Q4 2025 | 0.69 | 1.65 | +139.13% | $269.1M | ✅ Beat | -8.74% | -9.25% | -14.06% |
| 2025-11-03 |
| Q3 2025 |
| -0.14 |
| 0.38 |
| +371.43% |
| $224.5M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-04 | Q2 2025 | 0.21 | 0.45 | +114.29% | $217.1M | ✅ Beat | -21.12% | -38.72% | -34.13% |
| 2025-05-05 | Q1 2025 | -0.23 | 0.10 | +143.48% | $201.3M | ✅ Beat | +1.98% | -1.45% | -13.12% |
| 2025-02-10 | Q4 2024 | 0.71 | 1.15 | +61.97% | $239.7M | ✅ Beat | +1.66% | -0.50% | -10.20% |
| 2024-11-04 | Q3 2024 | 0.08 | 0.60 | +650.00% | $203.2M | ✅ Beat | +3.26% | +4.84% | +2.18% |
| 2024-08-06 | Q2 2024 | -0.15 | 0.32 | +313.33% | $195.9M | ✅ Beat | +28.14% | +30.73% | +34.17% |
Showing last 8 quarters.